Janux Therapeutics, Inc.
NASDAQ: JANXLa Jolla, US · Founded 2017 · Delaware corporation · 1 known investors
Clinical-stage biopharmaceutical company developing novel therapeutics.
Biotech
Founders & leadership
JL
Jay Lichter, Ph.D.Director
JS
Jake Simson, Ph.D.Director
SH
Stefan HellerDirector
PT
Peter Thompson, M.D.Director
VL
Vickie L. CappsDirector
DC
David Campbell, Ph.D.Executive Officer, Director
SG
Sheila GujrathiDirector
TR
Tighe ReardonExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$125MraisedApr 2021 · 22 investors · BiotechnologyRule 506(b)
▶$125MraisedApr 2021 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay Lichter, Ph.D.Director
- Jake Simson, Ph.D.Director
- Stefan HellerDirector
- Peter Thompson, M.D.Director
- Vickie L. CappsDirector
- David Campbell, Ph.D.Executive Officer, Director
- Sheila GujrathiDirector
- Tighe ReardonExecutive Officer
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$56MraisedMar 2021 · 7 investors · BiotechnologyRule 506(b)
▶$56MraisedMar 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay Lichter, Ph.D.Director
- Jake Simson, Ph.D.Director
- Tighe ReardonExecutive Officer
- Stefan HellerDirector
- Peter Thompson, M.D.Director
- David Campbell, Ph.D.Executive Officer, Director
- Offering amount
- $56M
- Amount sold
- $56M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$11.4MraisedJul 2020 · 3 investors · BiotechnologyRule 506(b)
▶$11.4MraisedJul 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jay Lichter, Ph.D.Director
- Stefan HellerDirector
- Tighe ReardonExecutive Officer
- David Campbell, Ph.D.Executive Officer, Director
- Offering amount
- $15.9M
- Amount sold
- $11.4M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.